John Green recently released a video advocating for Danaher/Cepheid to reduce the cost of their GeneXpert tests to $5/test.
More details can be found in this MSF writeup: https://msfaccess.org/time-for-5
> The 'Time for $5' Campaign calls on US diagnostics corporation Cepheid, and its parent company Danaher, to drop the price of its lifesaving GeneXpert tests to US$5 a test, so that many more people can get fast, accurate disease diagnosis, and receive treatment right away.
Resolution Criteria:
If by the end of 2024, MSF or another similar source reports that TD and XDR-TB GeneXpert tests will BOTH cost $6 USD or less when sold in LMICs, this market will resolve YES. Otherwise, NO.
Fine print:
I've added some margin to the $5 ask account for inflation, varying currencies rounding differences, etc. I think $6 still is well within the range of what I would call "success"
There are a lot of potential oddities around different prices in different places/subsidies/etc that could happen. I reserve the right to make a judgment call in those cases. I will not trade on this market.
🏅 Top traders
# | Name | Total profit |
---|---|---|
1 | Ṁ164 | |
2 | Ṁ84 | |
3 | Ṁ41 | |
4 | Ṁ5 |